{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:40:23Z","timestamp":1770817223248,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088298","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T21:35:47Z","timestamp":1394141747000},"page":"e88298","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["PTEN Regulates BCRP\/ABCG2 and the Side Population through the PI3K\/Akt Pathway in Chronic Myeloid Leukemia"],"prefix":"10.1371","volume":"9","author":[{"given":"Fang-Fang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng-Shu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xie-Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"A Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"ref2","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"PC Nowell","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"JD Rowley","year":"1973","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"TG Lugo","year":"1990","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"M Deininger","year":"2005","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"HM Kantarjian","year":"2007","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","article-title":"Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study","volume":"110","author":"O Ottmann","year":"2007","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-04-2139","article-title":"Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate","volume":"11","author":"J Cortes","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/onc.2009.524","article-title":"Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia","volume":"29","author":"F Albano","year":"2010","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1038\/sj.onc.1208796","article-title":"Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia","volume":"24","author":"DJ Barnes","year":"2005","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V97.3.720","article-title":"Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3","volume":"97","author":"TL Holyoake","year":"2001","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"J Thomas","year":"2004","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","article-title":"Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump","volume":"104","author":"H Burger","year":"2004","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"LA Doyle","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"S Zhou","year":"2001","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-60761-416-6_12","article-title":"Impact of breast cancer resistance protein on cancer treatment outcomes","volume":"596","author":"DD Ross","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"L Doyle","year":"2003","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","article-title":"PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer","volume":"275","author":"J Li","year":"1997","journal-title":"Science"},{"key":"ref19","first-page":"1922","article-title":"Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers","volume":"55","author":"SL Peiffer","year":"1995","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1182\/blood.V91.11.4388","article-title":"Alterations of the MMAC1\/PTEN gene in lymphoid malignancies","volume":"91","author":"K Gronbaek","year":"1998","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2009-06-228130","article-title":"PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice","volume":"115","author":"C Peng","year":"2010","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stem.2009.01.007","article-title":"PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells","volume":"4","author":"AM Bleau","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref23","first-page":"Unit9 18","article-title":"Stem cell identification and sorting using the Hoechst 33342 side population (SP)","volume":"9","author":"MA Goodell","year":"2005","journal-title":"Curr Protoc Cytom Chapter"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1368-7646(03)00062-1","article-title":"Resistance to imatinib (Glivec): update on clinical mechanisms","volume":"6","author":"E Weisberg","year":"2003","journal-title":"Drug Resist Updat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"T Illmer","year":"2004","journal-title":"Leukemia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"C Ozvegy-Laczka","year":"2004","journal-title":"Mol Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-03-3344","article-title":"Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro","volume":"64","author":"PJ Houghton","year":"2004","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2005-10-4020","article-title":"Complex interaction of BCRP\/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression","volume":"108","author":"T Nakanishi","year":"2006","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2006-02-003145","article-title":"Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate","volume":"108","author":"NE Jordanides","year":"2006","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"J Zhang","year":"2006","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"OH Yilmaz","year":"2006","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"GQ Daley","year":"1990","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"H Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2009.166","article-title":"Nilotinib concentration in cell lines and primary CD34(+) chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters","volume":"23","author":"A Davies","year":"2009","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1182\/blood-2004-04-1335","article-title":"Discontinuation of imatinib therapy after achieving a molecular response","volume":"104","author":"J Cortes","year":"2004","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"R Bhatia","year":"2003","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/stem.192","article-title":"Lack of ABCG2 expression and side population properties in human pluripotent stem cells","volume":"27","author":"H Zeng","year":"2009","journal-title":"Stem Cells"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4161\/cbt.11.11.15531","article-title":"The PTEN\/PI3K\/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells","volume":"11","author":"H Li","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbrc.2012.03.090","article-title":"PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter","volume":"420","author":"C Hegedus","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2013.04.006","article-title":"Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K\/Akt pathway in adult acute leukemia","volume":"336","author":"FF Huang","year":"2013","journal-title":"Cancer Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/nm1297-1337","article-title":"Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species","volume":"3","author":"MA Goodell","year":"1997","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0099917","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T02:31:52Z","timestamp":1597545112000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088298"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Viglietto","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088298","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0099917","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}